2019

Su J, Bylsma LC, Jiang X, Morales Arias J, Jain N, Nordyke RJ. Healthcare resource utilization among commercially insured cold agglutinin disease patients in the United States. Poster presentation at International Society for Pharmacoeconomics and Outcomes Research, New Orleans, Louisiana, May 18–22, 2019.

Mavunda K, Jiang X, Ambrose C. The prevalence of diagnosed chronic lung disease in US infants by gestational age: Implications for RSV policy. Celebration of Pediatric Pulmonology and Sleep, Orlando, FL, February 15–17, 2019.

Lowe K, Bylsma LC, Levin-Sparenberg ED, Sangaré L, Fryzek J, Alexander DD. Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer patients: A systematic literature review and meta-analysis. Poster presentation at Gastrointestinal Cancers Symposium, San Francisco, California, January 17-19, 2019.

Lowe K, Bylsma LC, Dean R, Gillezeau C, Sangaré L, Alexander DD, Fryzek J. The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis. Poster presentation at Gastrointestinal Cancers Symposium, San Francisco, California, January 2019.

2018

Ambrose C, Jiang X, Mavunda K. The prevalence of diagnosed chronic lung disease in US infants by gestational age: Implications for RSV policy. ID Week, San Francisco, California, October 4, 2018.

Fryzek JP, Bylsma LC, Nordyke RJ, Sorensen HT. Rare disease epidemiology: A Danish population-based program. Poster presented at National Organization for Rare Disorders’ Rare Disease and Orphan Products Breakthrough Summit, Washington, D.C., October 2018.

Cronin-Fenton D, Dalvi T, Fryzek J, Hansen H, Hamilton-Dutoit S, Hedgeman E, Mellemgaard A, Norgaard M, Pedersen L, Potter D, Rasmussen TR, Rigas J, Shire N, Sorensen HT, Walker J. PD-L1 expression, EGFR and KRAS mustations in stage III unresectables non-small cell lung cancer (NSCLC) patients. Presented at the International Society for Pharmacoepidemiology Annual Conference, August 22-26, 2018, Prague, Czech Republic.

Bylsma LC, Gulbech Ording A, Froslev T, Mehnert F, Fryzek J, Morales Arias J, Roth A, Sorensen HT, Berentsen S. Occurrence, survival, and thromboembolic risk in cold agglutinin disease: a population-based cohort analysis. Presented at the 23rd Congress of the European Hematology Association, June 14-17 2018, Stockholm, Sweden.

Cronin-Fenton D, Dalvi T, Hedgeman E, Norgaard M, Pedersen L, Hansen H, Fryzek J, Walker J, Mellemgaard A, Rasmussen TR, Shire N, Rigas J, Potter D, Hamilton-Dutoit S, Sorensen HT. PD-L1 expression, EGFR and KRAS mustations in stage III unresectables non-small cell lung cancer (NSCLC) patients. Presented at the American Association for Cancer Research (AACR) Annual Meeting 2018, April 14-18, 2018, Chicago, IL.

Bylsma LC, Gulbech Ording A, Froslev T, Mehnert F, Fryzek JP, Morales Arias J, Roth A, Sorensen HT, Berentsen S. Occurrence, survival, and thromboembolic risk in cold agglutinin disease: a population-based cohort analysis. Presented at the 23rd Congress of the European Hematology Association, June 14-17 2018, Stockholm, Sweden.